Ignite Creation Date:
2025-12-25 @ 1:16 AM
Ignite Modification Date:
2026-02-17 @ 5:05 PM
Study NCT ID:
NCT01985893
Status:
WITHDRAWN
Last Update Posted:
2016-01-14
First Post:
2013-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Lapatinib Plus Trastuzumab or Lapatinib Plus Capecitabine in Metastatic Breast Cancer
Sponsor:
Berufsverband Niedergelassener Gynäkologischer Onkologen in Deutschland e.V.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BNGO/01 THOR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |